Abstract |
One hundred and sixty-one Australian patients with hereditary bleeding disorders comprising hemophilia A (120), hemophilia B (18), von Willebrand's disease (16), and seven symptomatic female hemophilia A or B carriers were screened for clinical and serological evidence of exposure to HTLV-III/LAV/ARV/ HIV infection. During the previous five years (1979-1984) they had been treated almost exclusively with blood products derived from Australian voluntary donors. The prevalence of HTLV-III antibodies in 1985 was 45%, with the highest frequency being in those with severe hemophilia A (78%) and the lowest in patients with hemophilia B (6%). Antibody positivity correlated with a reduced absolute T helper (T4) cell numbers and/or an inverted T4:T8 ratio. Lymphadenopathy was detected in 23 subjects but only 13 had an abnormal T cell ratio. Comparison of seropositivity and T4:T8 ratios in 32 patients studied in 1983 and again in 1985 suggested that T4 cell deficiency reflected HTLV-III exposure rather than being a predisposing factor for infection with the virus. Individual patients showed considerable fluctuation in T cell subsets over a 12 month period of follow-up, but as a population there was a slight trend with time towards diminishing T4:T8 ratio only in the antibody positive hemophilia A patients of mild to moderate severity. Three (2%) of the 161 patients screened to date have developed confirmed AIDS with fatal outcome.(ABSTRACT TRUNCATED AT 250 WORDS)
|
Authors | R J Garsia, P A Gatenby, A Basten, D F Kenny, K J Gallagher, K A Rickard, I D Gust, W Maskill |
Journal | Australian and New Zealand journal of medicine
(Aust N Z J Med)
Vol. 17
Issue 4
Pg. 371-8
(Aug 1987)
ISSN: 0004-8291 [Print] Australia |
PMID | 2963611
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Viral
- Blood Coagulation Factors
- HIV Antibodies
|
Topics |
- Acquired Immunodeficiency Syndrome
(immunology, transmission)
- Antibodies, Viral
(analysis)
- Australia
- Blood Coagulation Factors
(therapeutic use)
- Blood Donors
- Blood Transfusion
- Female
- Follow-Up Studies
- HIV
(immunology)
- HIV Antibodies
- HIV Seropositivity
(immunology)
- Hemophilia A
(immunology, therapy)
- Humans
- Leukocyte Count
- Male
- Risk Factors
- T-Lymphocytes, Helper-Inducer
(immunology)
- T-Lymphocytes, Regulatory
(immunology)
|